ArticleCurrent opinion in toxicology2017

Is chronic AhR activation by rapidly metabolized ligands safe for the treatment of immune-mediated diseases?

Allison K Ehrlich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.